Stay updated on Pembrolizumab in 1st Line NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in 1st Line NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in 1st Line NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added Revision: v3.6.3 and removed Revision: v3.6.2, signaling a new page release. This appears to be a minor metadata/update rather than content changes to the study details.
    Difference
    0.0%
    Check dated 2026-07-03T23:59:39.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.2, replacing the previous Revision: v3.6.0 tag as part of a platform revision update.
    Difference
    0.0%
    Check dated 2026-06-26T23:42:02.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page now shows a recruitment status note ('No longer looking for participants') and adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated Intervention/Treatment section and a Revision: v3.6.0. The previous label 'Intervention / Treatment' has been replaced with 'Intervention/Treatment' and the older 'Revision: v3.5.5' tag was removed.
    Difference
    0.3%
    Check dated 2026-06-12T16:05:45.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.4 to v3.5.5, indicating a minor version update for the page. No substantive content or data changes are reflected in this change set.
    Difference
    0.0%
    Check dated 2026-06-05T11:42:33.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    A new publication citation has been added in Publications for the KEYNOTE-189 Japan extension study, with authors and journal details; the entry also indicates a version revision from v3.5.3 to v3.5.4.
    Difference
    0.1%
    Check dated 2026-05-14T23:18:55.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page shows an updated revision label 'Revision: v3.5.3' replacing the previous 'Revision: v3.5.2', indicating a software release rather than a change to the study data.
    Difference
    0.0%
    Check dated 2026-04-30T16:27:23.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in 1st Line NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in 1st Line NSCLC Clinical Trial page.